CDL Nuclear Technologies
Provider of turnkey cardiac PET, PET/CT, and SPECT solutions including facility buildout, scanners, ancillary equipment, radioactive isotopes and consumables
Recovery Pathways
Transaction Snapshot:
Service Type:
Sell-Side Advisory
Industry:
Business Services, Healthcare
Ownership:
Founder Owned
Location:
Pennsylvania
Buyer Type:
Strategic (Private Equity-Backed)
Confluence Advisors, LLC (“Confluence”) served as the exclusive advisor to Recovery Pathways, LLC with respect to its sale to BayMark Health Services (“BayMark”), a portfolio company of Webster Equity Partners.
Headquartered in Monroeville, Pennsylvania, Recovery Pathways is an office-based opioid treatment (“OBOT”) provider for patients suffering with addiction. The programs offer medication-assisted treatment (“MAT”) using buprenorphine-based medications in an outpatient, physician’s office setting. Buprenorphine-based medications include Suboxone®, Subutex® and Zubsolv®. Recovery Pathway’s three convenient locations in Southwestern Pennsylvania provide comprehensive treatment to patients with Opioid Use Disorder (“OUD”) from western Pennsylvania, Ohio and West Virginia.
Mike Saul, BayMark Division President, shared, “As we face an unprecedented health crisis across this country, it is easy to forget that the opioid epidemic continues to take more than 130 lives per day. Now, more than ever, people need safe, effective treatment options for substance use disorders. BayMark is proud to continue our work providing such treatment to those who need it, despite the current challenges, and are even more proud to do so through partnerships with providers such as Recovery Pathways.”
“Working with Confluence was without a doubt the biggest game changer we made for the sale of our company. Their networking reach, coupled with experience and professionalism, made selling our company a seamless process. I would recommend Confluence without reservation!” added Michael Mahoney, M.D., Co-Founder of Recovery Pathways.